When Apple Becomes the Forbidden Fruit

June 15, 2022 | Catherine Callaghan, Associate Research Analyst

For much of the last two years, big name tech stocks had been tantalizing fruit for investors willing to pay up for growth. Enter 2022. After peaking on January 4th, the S&P 500 has taken a nosedive, led by those same tech stocks. Since 2018, the Information Technology sector has grown from a 20.1% weight in the S&P 500 to 26.8%, setting it up to now have an outsized impact as equities correct. The largest detractors year-to-date, regardless of GICS sector classification, have business models and value propositions rooted in technological advancement and innovation. The top eight detractors this year are Apple, Microsoft, Amazon, Alphabet, Meta, Tesla, NVIDIA, and Netflix. These eight stocks have cost the index more than 800 basis points year-to-date, almost half of the S&P 500’s -17.6% return.¹

Behind the outsized correction in technology stocks are macro headwinds and rising rates. The instability caused by the Russia/Ukraine war, COVID-related shutdowns in China, ongoing supply chain disruptions, and heightened inflation has led to shifts out of longer-duration growth stocks towards the perceived safety of assets like gold and value stocks. Rising rates are weighing on growth stock multiples and increasing recessionary concerns are reducing confidence in outyear earnings projections. Uncertainty is high and sentiment is weak, and while risks certainly remain, that may eventually help support a market bottom. Up or down, large tech stocks will continue to have a meaningful impact on broader market returns.

Print PDF > When Apple Becomes the Forbidden Fruit

¹As of June 10, 2022

 

The opinions expressed herein are those of Marquette Associates, Inc. (“Marquette”), and are subject to change without notice. This material is not financial advice or an offer to purchase or sell any product. Marquette reserves the right to modify its current investment strategies and techniques based on changing market dynamics or client needs.

Catherine Callaghan
Associate Research Analyst

Get to Know Catherine

The opinions expressed herein are those of Marquette Associates, Inc. (“Marquette”), and are subject to change without notice. This material is not financial advice or an offer to purchase or sell any product. Marquette reserves the right to modify its current investment strategies and techniques based on changing market dynamics or client needs.

Related Content

10.10.2024

The Elusive Small-Cap Revival

U.S. small-cap equities have trailed their larger peers for over 13 years. Although the asset class has shown intermittent signs…

10.03.2024

Can Interest Rate Cuts Revive Private Equity?

It has been well documented that private equity has been experiencing pressures over the past two years, marked by declines…

10.02.2024

3Q 2024 Market Insights Webinar

— LIVE WEBINAR OCTOBER 23 — Please join Marquette’s research team for our 3Q 2024…

09.27.2024

Lower Rates, Better Fates?

With the first Federal Reserve rate cut of the current loosening cycle in the rear-view mirror, investors are now questioning…

09.19.2024

Keep Your Eye on the Labor Market

The Fed turned the page and began lowering interest rates with an outsized 50 bp cut at its September FOMC…

09.18.2024

A Cross Pacific Current

The pullback in global equity indices at the beginning of August left many investors racing to understand what had caused…

More articles

Subscribe to Research Email Alerts

Research Email Alert Subscription

Research alerts keep you updated on our latest research publications. Simply enter your contact information, choose the research alerts you would like to receive and click Subscribe. Alerts will be sent as research is published.

We respect your privacy. We will never share or sell your information.

Thank You

We appreciate your interest in Marquette Associates.

If you have questions or need further information, please contact us directly and we will respond to your inquiry within 24 hours.

Contact Us >